Baby Girl, Cabilez .
HRN: 25-67-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
01/08/2025
01/15/2025
PO
0.5
Q8h
Oral Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes